Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel

BACKGROUND: Chemotherapy with praziquantel (PZQ) is the mainstay of schistosomiasis control. However, there are recent concerns about tolerance or resistance to PZQ, so that monitoring its efficacy in different settings is required. METHODS: A longitudinal study was conducted to evaluate the impact...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ahmed, Abedaziz M, Abbas, Hana, Mansour, Fathi A, Gasim, Gasim I, Adam, Ishag
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434009/
https://ncbi.nlm.nih.gov/pubmed/22676052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-3305-5-108
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items